Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
4.000
-0.090 (-2.20%)
At close: Nov 14, 2025, 4:00 PM EST
3.900
-0.100 (-2.50%)
After-hours: Nov 14, 2025, 7:40 PM EST
Turn Therapeutics Statistics
Total Valuation
TTRX has a market cap or net worth of $112.09 million. The enterprise value is $109.08 million.
| Market Cap | 112.09M |
| Enterprise Value | 109.08M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TTRX has 28.02 million shares outstanding. The number of shares has increased by 3.81% in one year.
| Current Share Class | 28.02M |
| Shares Outstanding | 28.02M |
| Shares Change (YoY) | +3.81% |
| Shares Change (QoQ) | +1.77% |
| Owned by Insiders (%) | 62.36% |
| Owned by Institutions (%) | n/a |
| Float | 9.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 222.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.43 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2,324.83% and return on invested capital (ROIC) is -1,195.07%.
| Return on Equity (ROE) | -2,324.83% |
| Return on Assets (ROA) | -78.67% |
| Return on Invested Capital (ROIC) | -1,195.07% |
| Return on Capital Employed (ROCE) | -200.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.90M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 38.35 |
| Average Volume (20 Days) | 110,221 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.99M |
| Pretax Income | -3.80M |
| Net Income | -3.80M |
| EBITDA | -3.94M |
| EBIT | -3.99M |
| Earnings Per Share (EPS) | -$0.15 |
Balance Sheet
The company has $3.11 million in cash and $91,173 in debt, giving a net cash position of $3.01 million or $0.11 per share.
| Cash & Cash Equivalents | 3.11M |
| Total Debt | 91,173 |
| Net Cash | 3.01M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 504,019 |
| Book Value Per Share | 0.02 |
| Working Capital | 985,486 |
Cash Flow
| Operating Cash Flow | -1.82M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TTRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.81% |
| Shareholder Yield | -3.81% |
| Earnings Yield | -3.39% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |